Centinel Spine Marks 250th Procedure with prodisc Devices

Centinel Spine announced completion of the 250th procedure in the U.S. with its newly FDA-approved cervical total disc replacement system of prodisc solutions.

prodisc C Vivo has been in clinical use internationally since 2009 and is reportedly one of the most frequently implanted total disc replacement devices in the world. The device has a streamlined surgical technique with keel-less fixation and combines an anatomically-designed superior endplate with lateral spikes to optimize fit and provide immediate fixation.

prodisc C SK features a flat endplate design for optimal implant positioning that allows surgeons to address individual patient anatomy, and a low-profile central keel that provides immediate fixation and enables a streamlined keel preparation technique.

Both the prodisc C Vivo and prodisc C SK incorporate prodisc CORE technology, the basis behind the predictable clinical outcomes of the prodisc platform after 30 years and over 225,000 implantations worldwide.

Source: Centinel Spine, LLC